The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome

Yilmaz, M; Karakoc, A; Toruner, FB; Cakir, N; Tiras, M.BÜLENT; Ayvaz, G; Arslan, M

doi:10.1080/09513590500231627

The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome

Yilmaz M., Karakoc A., Toruner F., Cakir N., Tiras B., Ayvaz G., ...Daha Fazla

GYNECOLOGICAL ENDOCRINOLOGY, cilt.21, sa.3, ss.154-160, 2005 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 21 Sayı: 3
Basım Tarihi: 2005
Doi Numarası: 10.1080/09513590500231627
Dergi Adı: GYNECOLOGICAL ENDOCRINOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.154-160
Anahtar Kelimeler: polycystic ovary syndrome, menstrual cyclicity, hirsutism, metformin, rosiglitazone, INSULIN-RESISTANCE, CLOMIPHENE CITRATE, OBESE WOMEN, DOUBLE-BLIND, INDUCED OVULATION, THERAPY IMPROVES, HORMONE-BINDING, HYPERANDROGENISM, ENDOCRINE, GROWTH
Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

Objective. The aim of the present study was to assess the effects of metformin and rosiglitazone on menstrual cyclicity and hirsutism in patients with polycystic ovary syndrome (PCOS).